Defining the Clinical Target Volume: From the Art to the Science-AM2018
The definition of the clinical target volume (CTV) is becoming the weakest link in the radiotherapy chain. In this session we will first review some of the challenges of the standard CTV definition process (the "art"). We will then present new approaches that are being developed to move CTV definition from an art to a science. These include advances in imaging to make the invisible CTV extension visible, advances in machine learning to support the clinician in defining the CTV, and developments in robust treatment planning to incorporate uncertainties of the CTV in the treatment planning process.
This activity is available from January 11, 2019, through 11:59 p.m. Eastern time on January 10, 2022.
This activity was originally recorded at ASTRO’s 2018 Annual Meeting, October 22-24, 2018 in San Antonio, TX.
This course is designed to meet the interests of radiation oncologists, radiation physicists, diagnostic radiologists, and radiation biologists.
- Explain how machine learning tools can help to define the clinical target volume.
- Explain how uncertainties in defining the clinical target volume can be included in the treatment planning process through sensitivity analysis and robust optimization.
Laurence Court, PhD is employed at the UT MD Anderson Cancer Center and has nothing to disclose.
Anca Grosu, MD has nothing to disclose.
Robert Jeraj, PhD is employed by the University of Wisconsin and has nothing to disclose.
Thomas Bortfeld, PhD is employed by the Massachusetts General Hospital and receives compensation/remuneration/funding from RaySearch AB, Stockholm Sweden.
Additionally, the SA-CME Task Force and CME/MOC Committee had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.
- No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
- No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
- ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.